Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05922605
Other study ID # Caudal S-ketamine
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date June 20, 2023
Est. completion date May 1, 2025

Study information

Verified date October 2023
Source First Affiliated Hospital, Sun Yat-Sen University
Contact tao Zhang, MD
Phone 8613580482938
Email zhtao98@aliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious. Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.


Description:

Forty-four children scheduled for hypospadias randomize into 2 groups. Group E (n=22) (0.2% ropivacaine 0.7 ml/kg and S-ketamine 0.5 mg/kg), group C(n=22)( 0.2%ropivacaine 0.7ml/kg and equivalent saline) intraoperative and postoperative hemodynamics will be recorded. Postoperative pain is assessed using an established 6-item FLACC score at 1h,3h,6h,12h,24h,48h, or the time when children complain of pain after surgery. A score of more15μg/kg is administered.Investigators propose to compare the duration of caudal analgesia provided by plain ropivacaine and by a mixture of ropivacaine and S-ketamine.


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date May 1, 2025
Est. primary completion date April 30, 2025
Accepts healthy volunteers No
Gender Male
Age group 3 Months to 18 Years
Eligibility Inclusion Criteria: - informed parent consent, ASA I or II children, between 3months and 18 years of age,and weighing <28kg, scheduled for elective hypospadias surgery with general anesthesia will be recruited. Exclusion Criteria: - Patients who have congenital abnormalities of lower spine and meninges. - Patients with hypersensitivity to any local anesthetics - Children with coagulation disorders - Presence of Infections at puncture sites - Preexisting neurological disease - Refusal to consent by parent/guardian

Study Design


Intervention

Drug:
S-ketamine & Ropivacaine
The experiment group (Group E) will receive a mixture of ropivacaine 0.2% 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.
Ropivacaine
The experiment group (Group C) will receive ropivacaine 0.2% 0.7 ml/kg plain and equial volume saline caudally for postoperative analgesia.

Locations

Country Name City State
China First Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Tao Zhang

Country where clinical trial is conducted

China, 

References & Publications (7)

Brenner L, Marhofer P, Kettner SC, Willschke H, Machata AM, Al-Zoraigi U, Lundblad M, Lonnqvist PA. Ultrasound assessment of cranial spread during caudal blockade in children: the effect of different volumes of local anaesthetics. Br J Anaesth. 2011 Aug;107(2):229-35. doi: 10.1093/bja/aer128. Epub 2011 Jun 3. — View Citation

De Negri P, Ivani G, Visconti C, De Vivo P. How to prolong postoperative analgesia after caudal anaesthesia with ropivacaine in children: S-ketamine versus clonidine. Paediatr Anaesth. 2001 Nov;11(6):679-83. doi: 10.1046/j.1460-9592.2001.00742.x. — View Citation

Gunes Y, Secen M, Ozcengiz D, Gunduz M, Balcioglu O, Isik G. Comparison of caudal ropivacaine, ropivacaine plus ketamine and ropivacaine plus tramadol administration for postoperative analgesia in children. Paediatr Anaesth. 2004 Jul;14(7):557-63. doi: 10.1111/j.1460-9592.2004.01220.x. — View Citation

Koinig H, Marhofer P, Krenn CG, Klimscha W, Wildling E, Erlacher W, Nikolic A, Turnheim K, Semsroth M. Analgesic effects of caudal and intramuscular S(+)-ketamine in children. Anesthesiology. 2000 Oct;93(4):976-80. doi: 10.1097/00000542-200010000-00017. — View Citation

Martindale SJ, Dix P, Stoddart PA. Double-blind randomized controlled trial of caudal versus intravenous S(+)-ketamine for supplementation of caudal analgesia in children. Br J Anaesth. 2004 Mar;92(3):344-7. doi: 10.1093/bja/aeh076. Epub 2004 Jan 22. — View Citation

Narasimhan P, Kashyap L, Mohan VK, Arora MK, Shende D, Srinivas M, Kashyap S, Nath S, Khanna P. Comparison of caudal epidural block with paravertebral block for renal surgeries in pediatric patients: A prospective randomised, blinded clinical trial. J Clin Anesth. 2019 Feb;52:105-110. doi: 10.1016/j.jclinane.2018.09.007. Epub 2018 Sep 19. — View Citation

Weber F, Wulf H. Caudal bupivacaine and s(+)-ketamine for postoperative analgesia in children. Paediatr Anaesth. 2003 Mar;13(3):244-8. doi: 10.1046/j.1460-9592.2003.01018.x. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary duration of caudal analgesia Duration of analgesia is defined as the time from caudal injection to the first need for systemic analgesia. 48 hours after the caudal injection
Secondary morphine consumption The Face, Legs, Activity, Cry, and Consolability (FLACC) scale at 1 hour (h), 3h,6h,12h,24h,48h or the time when children complain of pain after surgery. A score of more than 3 points is taken as an indication of inadequate analgesia and morphine 15ug/kg was administered . 48 hours after caudal block
Secondary FLACC score The Face, Legs, Activity, Cry, and Consolability (FLACC) scale 48 hours after the caudal block
Secondary complication the incidence of residual motor block, urinary retention, paraesthesia; the incidence of respiratory depression ,vomiting ,nystagmus ,pruritus,odd behavior;.the sedation scores etc. 48 hours after the caudal block
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05975658 - WIReD: Wireless Interstage Remote Device Study
Completed NCT03921346 - Reducing Prehospital Medication Errors & Time to Drug Delivery by EMS During Simulated Pediatric CPR N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT04301206 - Videos and Simple Text to Empower Parents to Handle Their Sick Children N/A
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05480930 - Improving Nighttime Access to Care and Treatment; Part 4-Haiti N/A
Not yet recruiting NCT05815563 - Validation of Peripheral Perfusion Index in Predicting Successful Supraclavicular Brachial Plexus Block in Pediatrics
Recruiting NCT02556541 - Ultrasound-guided Peripheral Vascular Access in Children N/A
Recruiting NCT02908113 - Visual Perception in Preterm Infants N/A
Not yet recruiting NCT01678066 - A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor N/A
Completed NCT04993599 - Evaluation of Social Robot Usability for Pediatric Patients and Carers N/A
Completed NCT05537168 - Bayesian Networks in Pediatric Cardiac Surgery
Completed NCT01603628 - BOTOX® Treatment in Pediatric Lower Limb Spasticity Phase 3
Completed NCT01603615 - BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity Phase 3
Completed NCT06098105 - Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block vs Laparoscopic Intraperitoneal Instillation of Local Anesthetic in Pediatrics N/A
Completed NCT01418846 - Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients N/A
Completed NCT01460329 - Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO N/A
Withdrawn NCT00666393 - An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients Phase 3
Recruiting NCT03337581 - Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric Phase 4
Recruiting NCT05275881 - Impact of Virtual Reality in Pediatric Hematology and Oncology N/A